Patent ID: 11912777
Assignee: NANJING LEADS BIOLABS CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 1:
2. An anti-TNFR2 antibody or the antigen-binding fragment thereof, which comprises (i) three heavy chain complementary determining regions (CDRs) HCDR1, HCDR2, and HCDR3 consisting of the amino acid sequence of SEQ ID NO: 1, 2, and 3, respectively, and three light chain complementary determining regions (CDRs) LCDR1, LCDR2, and LCDR3 consisting of the amino acid sequence of SEQ ID NO: 4, 5, and 6, respectively; or (ii) three heavy chain complementary determining regions (CDRs) HCDR1, HCDR2, and HCDR3 consisting of the amino acid sequence of SEQ ID NO: 9, 10, and 11, respectively, and three light chain complementary determining regions (CDRs) LCDR1, LCDR2, and LCDR3 consisting of the amino acid sequence of SEQ ID NO: 12, 13, and 14, respectively.